NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
(NASDAQ: NRXP) Delayed: 3.49 +0.06 (1.75%)
Previous Close $3.43    52 Week High
Open $3.43    52 Week Low
Day High $3.50    P/E N/A 
Day Low $3.39    EPS
Volume 487,721       

(NASDAQ: NRXP) Delayed: 3.49 +0.06 (1.75%)
Previous Close $3.43    52 Week High
Open $3.43    52 Week Low
Day High $3.50    P/E N/A 
Day Low $3.39    EPS
Volume 487,721